We at BioNTech believe that adhering to the highest Corporate Governance standards positively impacts our performance and we put great importance on building trust with investors, the public and other stakeholders. We are committed to transparency of corporate communication and cooperation between our Management and Supervisory Board aimed at increasing shareholder value over the long term.
Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
|Audit Committee||Capital Markets Committee||Compensation, Nominating and Corporate Governance Committee|
|Helmut Jeggle||Capital Markets Committee|
|Dr. Ulrich Wandschneider||Audit Committee|
|Prof. Christopher Huber||Compensation, Nominating and Corporate Governance Committee|
|Michael Motschmann||Capital Markets Committee||Compensation, Nominating and Corporate Governance Committee|
|Prof. Dr. Anja Morawietz||Audit Committee||Capital Markets Committee|
|Prof. Dr. Rudolf Staudigl||Audit Committee||Compensation, Nominating and Corporate Governance Committee|